Ledger.Open graph →

SEC Form D · filed December 8, 2016

ApoGen Biotechnologies, Inc

Offering

$7.3M

Sold

$3.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Asish Xavier · New Brunswick, NJDirector Johnston Erwin · Indianapolis, INDirector Lindsay Rayle · Seattle, WAExec David Mcelligott · Seattle, WAExec Steve Gillis · Chicago, ILDirector Joel Marcus · Pasadena, CADirector Thong Le · Seattle, WAExec · Director John Santini · Chanhassen, MNDirector John E. Kingma · SEATTLE, WADirector David Schubert · Seattle, WAExec James Sullivan · New York, NYDirector Joel Marcus · New York, NYDirector Thong Le · Seattle, WAExec · Director Jeffery L. Henry · Bend, ORDirector David Schubert · Seattle, WAExec James Sullivan · Berkshire, United KingdomDirector Johnston Erwin · Indianapolis, INDirector Lindsay Rayle · Seattle, WAExec David Mcelligott · Seattle, WAExec Steve Gillis · Chicago, ILDirector Joel Marcus · Durham, NCDirector Thong Le · Seattle, WAExec · Director John Santini · Bedford, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗